Amarnath Natarajan

3.6k total citations
99 papers, 2.8k citations indexed

About

Amarnath Natarajan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Amarnath Natarajan has authored 99 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 22 papers in Organic Chemistry and 21 papers in Oncology. Recurrent topics in Amarnath Natarajan's work include Ubiquitin and proteasome pathways (12 papers), Cancer-related Molecular Pathways (9 papers) and DNA Repair Mechanisms (8 papers). Amarnath Natarajan is often cited by papers focused on Ubiquitin and proteasome pathways (12 papers), Cancer-related Molecular Pathways (9 papers) and DNA Repair Mechanisms (8 papers). Amarnath Natarajan collaborates with scholars based in United States, Canada and India. Amarnath Natarajan's co-authors include Sandeep Rana, Margaret Taylor, Yogesh A. Sonawane, Smitha Kizhake, Jacob I. Contreras, José A. Halperin, Muhammad Zahid, Yuhong Guo, Smit Kour and Hüseyin Aktaş and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Amarnath Natarajan

98 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amarnath Natarajan United States 28 1.6k 748 585 263 243 99 2.8k
Lisa Polin United States 32 1.6k 1.0× 583 0.8× 563 1.0× 151 0.6× 218 0.9× 102 3.0k
A. Chaikuad Germany 37 2.9k 1.8× 760 1.0× 784 1.3× 349 1.3× 296 1.2× 123 4.4k
Luoting Yu China 29 1.6k 0.9× 1.1k 1.5× 476 0.8× 148 0.6× 157 0.6× 141 2.9k
K. Huber United Kingdom 26 1.9k 1.1× 518 0.7× 665 1.1× 262 1.0× 168 0.7× 60 3.0k
Shingo Dan Japan 26 1.4k 0.9× 278 0.4× 493 0.8× 213 0.8× 191 0.8× 95 2.3k
Rima Al‐awar Canada 29 1.3k 0.8× 550 0.7× 498 0.9× 140 0.5× 124 0.5× 65 2.2k
Akira Asai Japan 33 1.8k 1.1× 938 1.3× 649 1.1× 337 1.3× 117 0.5× 132 3.0k
Chuan Shih United States 32 1.4k 0.9× 790 1.1× 687 1.2× 129 0.5× 352 1.4× 81 2.9k
Michelandrea De Cesare Italy 31 2.1k 1.2× 512 0.7× 1.0k 1.7× 197 0.7× 262 1.1× 94 3.0k
Mark J. Suto United States 30 1.5k 0.9× 564 0.8× 531 0.9× 147 0.6× 181 0.7× 88 2.6k

Countries citing papers authored by Amarnath Natarajan

Since Specialization
Citations

This map shows the geographic impact of Amarnath Natarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amarnath Natarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amarnath Natarajan more than expected).

Fields of papers citing papers by Amarnath Natarajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amarnath Natarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amarnath Natarajan. The network helps show where Amarnath Natarajan may publish in the future.

Co-authorship network of co-authors of Amarnath Natarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Amarnath Natarajan. A scholar is included among the top collaborators of Amarnath Natarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amarnath Natarajan. Amarnath Natarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azadmanesh, Jahaun, Medhanjali Dasgupta, Amarnath Natarajan, et al.. (2025). The role of Tyr34 in proton coupled electron transfer and product inhibition of manganese superoxide dismutase. Nature Communications. 16(1). 1887–1887. 1 indexed citations
2.
Rana, Sandeep, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.. (2024). Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects. Cancer Research Communications. 4(5). 1328–1343. 2 indexed citations
3.
4.
Mohan, Kabhilan, Sandeep Rana, Sarbjit Singh, et al.. (2024). The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax. SHILAP Revista de lepidopterología. 5(3). 321–340. 2 indexed citations
5.
Tolosa, Ezequiel J., Lin Yang, Jennifer Ayers-Ringler, et al.. (2024). Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors. Communications Biology. 7(1). 1719–1719. 3 indexed citations
6.
Harris, Rebecca, Ming Yang, Christina Schmidt, et al.. (2022). Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells. The Journal of Cell Biology. 221(7). 11 indexed citations
7.
Kour, Smit, Sandeep Rana, Smitha Kizhake, et al.. (2022). Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells. Journal of Biological Chemistry. 298(5). 101890–101890. 8 indexed citations
8.
Rana, Sandeep, Smit Kour, Smitha Kizhake, et al.. (2022). Dimers of isatin derived α-methylene-γ-butyrolactone as potent anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 65. 128713–128713. 7 indexed citations
9.
Yin, Ling, Yongji Zeng, Yuanhong Chen, et al.. (2021). Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer. Oncogene. 40(50). 6772–6785. 10 indexed citations
10.
Kolar, Carol, et al.. (2019). A simple fluorescent assay for the discovery of protein-protein interaction inhibitors. Analytical Biochemistry. 569. 46–52. 8 indexed citations
11.
Robb, Caroline M., Jacob I. Contreras, Smit Kour, et al.. (2017). Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chemical Communications. 53(54). 7577–7580. 177 indexed citations
12.
Hein, Ashley L., Yuri Sheinin, Imayavaramban Lakshmanan, et al.. (2016). RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Oncogene. 35(49). 6319–6329. 57 indexed citations
13.
Mundra, Vaibhav, Yang Peng, Sandeep Rana, Amarnath Natarajan, & Ram I. Mahato. (2015). Micellar formulation of indocyanine green for phototherapy of melanoma. Journal of Controlled Release. 220(Pt A). 130–140. 51 indexed citations
14.
Luan, Haitao, Bhopal Mohapatra, Gulzar Ahmad, et al.. (2014). A Kinase Inhibitor Screen Reveals Protein Kinase C-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells. Journal of Biological Chemistry. 289(44). 30443–30458. 30 indexed citations
15.
Chaturvedi, Nagendra K., Rajkumar N. Rajule, Prakash Radhakrishnan, et al.. (2013). Novel Treatment for Mantle Cell Lymphoma Including Therapy-Resistant Tumor by NF-κB and mTOR Dual-Targeting Approach. Molecular Cancer Therapeutics. 12(10). 2006–2017. 25 indexed citations
16.
Radhakrishnan, Prakash, Rajkumar N. Rajule, Nagsen Gautam, et al.. (2013). Targeting the NF-κB and mTOR Pathways with a Quinoxaline Urea Analog That Inhibits IKKβ for Pancreas Cancer Therapy. Clinical Cancer Research. 19(8). 2025–2035. 24 indexed citations
17.
Ramesh, J., et al.. (2011). Effect of enzyme supplementaion on digestibilty and metabolizability of nutrients in cockerels. Indian Journal of Animal Research. 45(2). 143–147. 1 indexed citations
18.
Campbell, Stephen J., et al.. (2011). Exploiting the P-1 Pocket of BRCT Domains Toward a Structure Guided Inhibitor Design. ACS Medicinal Chemistry Letters. 2(10). 764–767. 20 indexed citations
19.
Palermo, Nicholas Y. & Amarnath Natarajan. (2011). Beyond the frog: The evolution of homology models of human IKKβ. Bioorganic & Medicinal Chemistry Letters. 21(20). 6081–6084. 1 indexed citations
20.
Ahmed, Khalil, et al.. (2010). Antihyperglycemic and antihyperlipidemic effect of ethyl acetate flower extract of Cassia auriculata on alloxan induced diabetes in male albino rats.. Journal of Pharmacy Research. 3(6). 1300–1303. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Polin Breakdown of academic impact, for papers by A. Chaikuad Breakdown of academic impact, for papers by Luoting Yu Breakdown of academic impact, for papers by K. Huber Breakdown of academic impact, for papers by Shingo Dan Breakdown of academic impact, for papers by Rima Al‐awar Breakdown of academic impact, for papers by Akira Asai Breakdown of academic impact, for papers by Chuan Shih Breakdown of academic impact, for papers by Michelandrea De Cesare Breakdown of academic impact, for papers by Mark J. Suto
Rankless by CCL
2026